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Loss of muscle mass and force occurs in many diseases such as disuse/inactivity,
diabetes, cancer, renal, and cardiac failure and in aging-sarcopenia. In these catabolic
conditions the mitochondrial content, morphology and function are greatly affected.
The changes of mitochondrial network influence the production of reactive oxygen
species (ROS) that play an important role in muscle function. Moreover, dysfunctional
mitochondria trigger catabolic signaling pathways which feed-forward to the nucleus
to promote the activation of muscle atrophy. Exercise, on the other hand, improves
mitochondrial function by activating mitochondrial biogenesis and mitophagy, possibly
playing an important part in the beneficial effects of physical activity in several diseases.
Optimized mitochondrial function is strictly maintained by the coordinated activation of
different mitochondrial quality control pathways. In this review we outline the current
knowledge linking mitochondria-dependent signaling pathways to muscle homeostasis
in aging and disease and the resulting implications for the development of novel
therapeutic approaches to prevent muscle loss.
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INTRODUCTION
Nearly 40–50% of total body mass in non-obese mammals is composed by skeletal muscles.
Striated muscles are plastic tissues that can undergo adaptive changes in their structure or
functional properties to meet new challenges. For example, muscle mass can either increase
or decrease in response to metabolic demands like exercise or inactivity. Moreover, muscle
strength or resistance to fatigue can be modulated by training or detraining. The regulation of
muscle size, due to its limited proliferative capacity, is determined by the coordinated balance
between protein synthesis and protein degradation. Mechanical overload or anabolic hormonal
stimulation shifts the balance toward protein synthesis with consequent increases in fiber size,
a process called hypertrophy. Conversely, in catabolic conditions protein degradation exceeds
protein synthesis leading to muscle weakness and muscle atrophy. The decrease in cell size is
mainly due to loss of organelles, cytoplasm and proteins. Skeletal muscle atrophy occurs in
several pathological conditions like disuse, denervation, immobilization, sepsis, burn injury, cancer,
AIDS, diabetes, heart and renal failure and during aging. Importantly, the decrease of muscle
mass increases morbity, impairs the efficacy of many therapeutic treatments and contributes to
mortality. Muscle mass is mainly controlled by two major signaling pathways: TGFβ/Smads and
IGF1-AKT-mTOR-FoxO. TGFβ superfamily of ligands regulate the size of muscles via the Smad
transcription factors (Sandri, 2013). Smad2/3 control catabolic genes while Smad1/5/8 regulate
anabolic genes (Sartori et al., 2013, 2014). The IGF1-AKT- mTOR axis increases protein synthesis
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by stimulating the translational machinery while simultaneously
blocking FoxOs transcription factors and protein degradation
pathways (Sandri, 2013). Two main ATP-dependent proteolytic
systems are activated during muscle atrophy in order to
contribute to muscle loss. The ubiquitin-proteasome system
degrades predominantly myofibrillar proteins, whereas the
autophagy-lysosome system removes dysfunctional organelles,
protein aggregates as well as unfolded and toxic proteins. Muscle
atrophy requires the activation of gene transcription programs
that regulate the expression of a subset of genes that are named
atrophy-related genes or atrogenes (Bodine et al., 2001; Gomes
et al., 2001; Lecker et al., 2004; Sandri et al., 2004; Sacheck et al.,
2007). These atrogenes belong to several fundamental biological
processes such as the ubiquitin-proteasome and autophagy-
lysosome systems, protein syntesis, ROS detoxification, DNA
repair, unfolding protein response (UPR), mitochondria function
and energy balance. FoxO family of transcription factors (FoxO1,
FoxO3, and FoxO4), which are targets of AKT, are key mediators
of the catabolic response during atrophy (Sandri et al., 2004;
Mammucari et al., 2007; Milan et al., 2015). Indeed, specific
inhibition of FoxOs in muscle protects from cancer cachexia-,
fasting- or denervation-induced atrophy (Judge et al., 2014;
Milan et al., 2015) as they are critical for the regulation of
several atrogenes. Moreover, at least half of the atrogenes require
FoxOs for their up or downregulation (Milan et al., 2015). FoxO-
dependent atrogenes include the E3 Ubiquitin ligases Atrogin-1,
MuRF-1, MUSA1, SMART, and several autophagy-related genes
such as LC3, GABARAPL1, BNIP3, CATHEPSIN L (Bodine
et al., 2001; Sandri et al., 2004; Mammucari et al., 2007; Milan
et al., 2015). Therefore, FoxOs coordinate both major proteolytic
systems of the cell, the autophagy-lysosome and the ubiquitin-
proteasome.
Interestingly, in addition to genes linked with proteolytic
pathways, more than 10% of the atrophy-related genes are
directly involved in energy production. Furthermore, several
genes coding for enzymes important in glycolysis and oxidative
phosphorylation are coordinately suppressed in atrophying
muscles (Lecker et al., 2004). These interesting findings suggest
that alterations in mitochondria and the mitochondrial network
morphology can have potential deleterious consequences for the
maintenance of muscle mass and function. Recent data shows
that the mitochondrial network communicates with myonuclei
to adapt muscle function to the physiological or pathological
demands. Here we will review the principal pathways that control
mitochondrial quality and the importance of mitochondrial
network in the regulation of muscle mass and metabolism.
OPTIMIZATION OF MITOCHONDRIAL
FUNCTION: A QUALITY CONTROL ISSUE
Mitochondria are continuously challenged by reactive
oxygen species (ROS), an inexorable by-product of oxidative
phosphorylation. In order to prevent an excessive production of
ROS but also the release of dangerous factors such as cytochrome
c, AIF or endonuclease G, mammalian cells contain several
systems that maintain mitochondrial integrity and function.
This mitochondrial quality control includes pathways related
to protein folding and degradation as well as systems involved
in organelle shape, movement and turnover (Figure 1). The
activation of each specific quality control system depends on the
degree of mitochondrial damage.
Mitochondrial Proteolysis Controls Both
Mitochondrial Protein Turnover
and Mitochondrial Function
Proteomic studies identified in human mitochondria
approximately 1200 proteins (Calvo et al., 2015). However,
only 1% of these proteins is encoded by mitochondrial DNA
(mtDNA) (13 proteins in humans). Therefore, the remaining
99% is encoded by nuclear DNA (nDNA) genes, which are
synthesized by ribosomes in cytoplasm and are imported into
mitochondria (Harbauer et al., 2014). The incorporation of these
precursors into specific mitochondria subcompartments such as
the outer mitochondrial membrane (OMM), the intermembrane
space (IMS), the inner mitochondrial membrane (IMM) and the
mitochondrial matrix requires a specific and highly regulated
import machineries (Harbauer et al., 2014). To maintain the
proteostasis in each mitochondrial compartment, specific
proteases (mitoproteases) will rapidly degrade misfolded or
oxidized proteins. Mitoproteases-mediated quality control is the
first line of defense against a mild mitochondrial damage. In the
mitochondrial matrix, protein turnover is controlled by 3 AAA
proteases: the soluble Lon and ClpP and the membrane-bound
m-AAA. Protein degradation in the IMS is controlled by the
membrane-bound i-AAA Yme1L1, the soluble HtrA2/Omi, the
metallopeptidases OMA1 and the rhomboid protease PARL.
Different reports showed that these mitoproteases do not only
monitor mitochondrial protein quality but they can also decide
mitochondrial fate. For example, m -AAA, Yme1L1, HtrA2,
OMA1, and PARL l cleave the profusion protein Opa1 affecting
mitochondrial morphology and function (Alavi and Fuhrmann,
2013). In addition, PARL modulates mitophagy by degrading the
mitophagy protein PINK1 (Jin et al., 2010). For a review on the
roles and the pathological relevance of these mitoproteases please
refer to Quiros et al. (2015). Beside subcompartment-specific
proteases, mitochondrial protein turnover is regulated also by
the cytosolic ubiquitin-proteasome system (UPS). The UPS
marks proteins for proteasomal degradation by the covalent
linkage of a chain of ubiquitin proteins. A proteomic study in
mouse cardiac muscle identified numerous OMM as well as IMS,
IMM, and matrix proteins to be ubiquitinated (Jeon et al., 2007).
A still unanswered question is how the cytosolic proteasome
can degrade integral mitochondrial membrane proteins. During
ER stress, misfolded proteins accumulate into the ER lumen
and need to be retrotranslocated into the cytosol where they
are flagged with ubiquitin and degraded by the proteasome in
a process called ER-associated protein degradation (ERAD).
Mitochondria have an ERAD-likemechanism, themitochondria-
associated degradation (MAD) pathway (Heo et al., 2010). ERAD
and MAD pathways share some key components like the AAA
ATPase p97 and the cofactor Npl4 (Ye et al., 2003; Heo et al.,
2010). p97/Npl4 complex regulates the retrotranslocation of
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FIGURE 1 | Mitochondrial quality control pathways are depicted. The actions of specific mitoproteases, Lon, ClpP, Oma1, Yme1L1, and PARL, maintain
mitochondrial proteostasis and regulate mitochondrial function. PARL, Oma1, and Yme1L1 control mitochondrial dynamics by proteollytically processing Opa1
protein, which is important for mitochondrial fusion and cristae remodeling. PARL degrades PINK1, regulating mitophagy. Drp1, Fis, and Mff are the major proteins
involved in mitochondrial fission. Partially damaged mitochondrial network divides into two fragments with different 19m. The fragment with higher 19m rejoins the
functional mitochondrial network through mitochondrial fusion. Depolarized organelles will be removed by mitophagy. Bnip3 acts as a mitophagic receptor, binding to
LC3 to tether mitochondria to the autophagosome. PINK1 accumulates on the surface of depolarized mitochondria where it phosphorylates ubiquitinated OMM
proteins and the Parkin UBL domain. Parkin will further promote the ubiquitination of the outer mitochondrial membrane proteins, like MFN1/2. Then, the ubiquitinated
proteins can be recognized by the adaptors p62/SQSTM1, Optineurin (OPTN), and NPD52 to initiate mitophagy.
proteins from both the ER (Ye et al., 2001, 2003) and OMM (Heo
et al., 2010; Tanaka et al., 2010; Xu et al., 2011). In mitochondria,
p97 provides the driving force to extract Mfn1, Mfn2 and the
anti-apoptotic protein Mcl1 from the OMM and chaperoned
them for their degradation by the proteasome in the cytosol
(Tanaka et al., 2010; Xu et al., 2011). Several components of
the UPS are recruited to mitochondria such as the E3 ligases
Parkin, March V/Mitol, Huwe, and Mulan (Livnat-Levanon
and Glickman, 2011).These mitochondrial E3 ligases are a
good example of the synergistic crosstalk between different
mitochondria quality control systems. For instance, the activity
of these ubiquitin ligases impacts on mitochondrial morphology
and half-life. Indeed, Parkin-mediated ubiquitination of Mfn1,
Mfn2, and VDAC1 blocks/reduces mitochondrial fusion
and promotes mitophagy (Narendra et al., 2008; Gegg et al.,
2010; Geisler et al., 2010; Tanaka et al., 2010). On the other
hand, in physiological conditions Parkin avoid mitochondrial
fragmentation by repressing Drp1 levels (Wang et al., 2011).
Finally, MarchV/Mitol ubiquitinates Drp1, Fis1, and mitofusins
1 and 2 (Nakamura et al., 2006; Yonashiro et al., 2006; Karbowski
et al., 2007). One intriguing issue is whether intramitochondrial
proteins that do not face the cytosol can be substrates of the
MAD pathway. Even though a retrotranslocation machinery
has not been identified, some evidence indicates that the UPS
controls IMM proteins. In fact, as a consequence of proximity
to the respiratory chain, IMM proteins are exposed to ROS
generated by mitochondrial respiration and therefore, oxidized.
For example, the mitochondrial uncoupling protein 2 (UCP2)
(Azzu and Brand, 2010; Bragoszewski et al., 2013) and the
subunit of the OXPHOS complex V OSCP have been found
to be retrotranslocated to the OMM for ubiquitination and
proteasome degradation (Margineantu et al., 2007). Indeed,
proteasome inhibition leads to accumulation of the IMM
proteins UCP2, COXI, III, IV, OSCP (Margineantu et al., 2007;
Azzu and Brand, 2010). Although the role of the UPS in different
cellular processes has been well characterized, studies concerning
the interaction with mitochondria are only at the beginning.
Several critical issues related to how substrates are identified and
how they are transported out for degradation need to be solved
in the future.
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Under stress conditions, when the degradation pathways
are not sufficient to blunt the damage and restore a normal
mitochondrial function, a retrograde signal is activated which
coordinates nuclear gene expression. This mitochondria-to-
nucleus response is named mitochondrial unfolding protein
response (UPRmt) (Zhao et al., 2002). The ultimate purpose of
UPRmt is tomaintain proteostasis by promoting the expression of
chaperones to improve protein folding, inhibit protein synthesis
to alleviate ER stress and to induce expression of m-AAA
proteases like ClpP and Yme1 to remove damaged proteins. For
reviews on this topic see (Jovaisaite and Auwerx, 2015; Schulz
and Haynes, 2015).
Mitochondrial Dynamics: Not Only a Matter
of Shape
Mitochondrial dynamics is defined by the capacity of the
organelle to rapidly change its size, shape and distribution by
continuously alternating fusion and fission events. Fusion leads
to elongated mitochondria with increased interconnectivity
into a tubular network. On the contrary, fission fragments the
network into unconnected shorter organelles. In physiological
conditions, most mammalian cells show a continuous
filamentous mitochondrial network with the exception of
cardiomyocytes that display fragmented mitochondria that
do not form a network (Song and Dorn, 2015). However, the
mitochondrial pool rapidly changes its morphology according
to the cellular needs. Increased mitochondrial fusion facilitates
the redistribution of metabolites, proteins and mtDNA within
the network. Moreover, fusion between healthy and damaged
organelles allows to dilute the damaged material into the healthy
network, avoids the accumulation of dysfunctional mitochondria
and maintains their overall fitness (function) (Twig et al., 2008).
On the other hand, mitochondrial fragmentation is a mechanism
that segregates dysfunctional or damaged components of the
mitochondrial network, allowing their removal via mitophagy
(Otera and Mihara, 2011).
However, excessive fission generates isolated mitochondria
which are less efficient in ATP production and are dysfunctional
because they consume ATP to maintain their membrane
potential (Benard et al., 2007).
Fusion Machinery
Mitochondrial structure is optimized to ensure respiration and
ATP production with a minimal release of ROS. This architecture
must be preserved during fusion and fission events. Therefore,
when mitochondria fuse they follow a scheme which starts with
mitochondrial tethering, continues with fusion of OMM and
concludes with fusion of IMM. In mammals, the membrane-
bound GTPases mitofusin 1 (Mfn1), mitofusin 2 (Mfn2), and
optic atrophy protein 1 (Opa1) are required for fusion of the
OMM and IMM respectively.
OMM profusion proteins
Mfn1 and Mfn2 are integrated into the OMM and have
two cytosolic heptad repeat domains (HR1 and HR2) which
interact to form a dimeric anti parallel coiled-coil structure.
Both mitofusins can consequently interact homotypically (Mfn1-
Mfn1, Mfn2-Mfn2) or heterotypically (Mfn1-Mfn2) to promote
the tethering of different adjacent mitochondria and fusion of
the OMMs (Koshiba et al., 2004).These proteins have a high
degree of homology but they do not have the same functions.
Mfn1 has higher GTPase and organelle fusion activity whileMfn2
has greater affinity for GTP (Ishihara et al., 2004). Aditionally,
Mfn2 and not Mfn1 is expressed on the mitochondria-associated
endoplasmic reticulummembranes (MAM) and to a lesser extent
to the endoplasmic/sarcoplasmic reticulum (ER/SR) (de Brito
and Scorrano, 2009). This unique distribution allows for the
close communication between the two organelles. Indeed, Mfn2
bridges mitochondria to ER/SR facilitating important processes
linked to ER-mitochondria interactions like calcium homeostasis
and signaling (de Brito and Scorrano, 2009; Ngoh et al., 2012;
Sebastian et al., 2012; Munoz et al., 2013; Ainbinder et al., 2015).
Recent data indicates Mfn2 as a modulator of the UPR during ER
stress. In fact, Mfn2 deficiency leads to fragmented ER network
and ER stress (Ngoh et al., 2012; Sebastian et al., 2012; Munoz
et al., 2013; Bhandari et al., 2015) by chronic activation of PERK
(Munoz et al., 2013). Mfn2, like the other mitochondria-shaping
proteins is not free from post-translational modifications. For
instance, when Mfn2 is phosphorylated by PINK1, it becomes a
receptor for the ubiquitin ligase Parkin (Chen and Dorn, 2013).
In addition, the E3 ligases HUWE1 andMul1 also promote Mfn2
ubiquitination and proteasomal degradation (Leboucher et al.,
2012; Lokireddy et al., 2012). Conversely, the formation of a
Lys63- polyubiquitin chain by the E3 ligase MARCHV/Mitol
does not induce Mfn2 degradation but increases its activity as
well as MAM formation and function (Sugiura et al., 2013).
Altogether, Mfn2 promotes mitochondrial fusion, enhances
ER-mitochondria and activates mitophagy via PINK1/Parkin
pathway.
Opa1: The pleiotropic IMM fusion protein
The profusion protein Opa1 is regulated by proteolytic
processing. There are several splicing variants of Opa1 (8 in
humans and 4 in mice) which are expressed in a tissue specific
manner. Some of them are cleaved to generate soluble short
Opa1 (Opa1S) from long Opa1 isoforms (Opa1L) (Ishihara et al.,
2006). Opa1L is anchored to the IMM by a transmembrane
domain at the N-terminus and can be further cleaved in exon
5 (site S1) by OMA1, a process that is mitochondrial membrane
potential(19m)-dependent (Ehses et al., 2009; Head et al., 2009).
The mitoprotease Yme1 cut the site S2 in exon 5b of a subset
of Opa1L belonging to the splicing variants 4, 6, 7, and 8
(Anand et al., 2014). As aforementioned, other mitoproteases
such as m -AAA, HtrA2, and PARL l are also involved in Opa1
processing (Alavi and Fuhrmann, 2013). Furthermore, Opa1
is cleaved in its C-terminal region by an unknown cysteine
protease in the post-prandial liver, in a process dependent on
Mfn2 and independent of OMA1 (Sood et al., 2014). Opa1-
dependentmitochondrial fusion needsMfn1 (Cipolat et al., 2004)
as well as Opa1S and Opa1L forms (Frezza et al., 2006; Song
et al., 2007). However, under stress conditions fusion can rely
only on Opa1L while Opa1S forms are dispensable (Tondera
et al., 2009; Anand et al., 2014). In addition, oligomerization of
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soluble and membrane-bound OPA1 isoforms controls cristae
remodeling and the assembly of respiratory chain complexes
into supercomplexes, a structure that enhances mitochondrial
respiration (Cogliati et al., 2013). On the contrary, complete
conversion of Opa1L into Opa1S inhibits fusion and increases
mitochondrial fission (Ishihara et al., 2006; Anand et al., 2014).
Fission Machinery
Mitochondrial fission depends on the cytosolic GTPase dynamin-
related protein 1 (Drp1). Drp1 is recruited to the OMM where
it assembles into multimeric ring complexes that form active
GTP-dependent mitochondrial fission sites (Smirnova et al.,
2001). Drp1 lacks hydrophobic membrane-binding domains
and for this reason its recruitment on OMM is dependent
on mitochondrial membrane proteins that act as receptors.
Accordingly, Drp1 interacts with the integral OMM proteins:
Fis1, Mff, mitochondrial elongation factor 2/mitochondrial
dynamics protein 49 (MIEF2/MiD49) and MIEF1/MiD51. Fis1
is the major Drp1 receptor in yeasts (Karren et al., 2005).
However, increasing evidence suggests that in mammals Fis1
is not the only OMM-anchor receptor of Drp1. For example,
downregulation of Fis1 leads to mitochondrial elongation, even
if the recruitment of Drp1 to mitochondria is not reduced
(Lee et al., 2004). Furthermore, conditional deletion of Fis1 in
a carcinoma model did not lead to defects in mitochondrial
fission, indicating that Fis1 is not essential for fission (Otera
et al., 2010). Recently, new components of the mammalian fission
machinery were identified (Otera et al., 2010; Palmer et al., 2011;
Zhao et al., 2011). Mff, the OMM-anchoredmitochondrial fission
factor, colocalizes with Drp1 on mammalian mitochondria. Its
overexpression promotes mitochondrial fission with increased
Drp1 recruitment to mitochondria. On the contrary, silencing
Mff generates elongated mitochondria and Drp1 cytosolic
distribution. Moreover, Drp1 affinity for Mff is higher than
for Fis, suggesting that Mff preferentially functions as Drp1
receptor (Otera et al., 2010). MIEF1/MiD51 and the variant
MIEF2/MiD49 recruit Drp1 to mitochondria independently of
Fis1or Mff. Moreover, overexpression of MiD51 does not induce
mitochondrial fragmentation but instead prevents mitochondrial
fission by sequestering and inhibiting Drp1 (Palmer et al., 2011,
2013; Zhao et al., 2011; Loson et al., 2013). MIEF1/MiD51
preferentially binds Fis1 but can also interact with DRP1 and
consequently, depending from the levels of Fis1, two different
protein complexes are generated. When the level of Fis1 is high,
it sequesters MIEF1/MiD51 that cannot anymore interact and
inhibit DRP1 allowing mitochondrial fission. In contrast, the
downregulation of Fis1 releases MIEF1/MiD51 that can now
block Drp1 resulting in mitochondrial fusion (Zhao et al., 2011).
Finally, in yeast Drp1 has been suggested to act as a regulatory
factor not only of fission but also of fusion (Huang et al.,
2011). In fact, it has been reported that mitochondria-localized
Drp1 can interact with the HR1 domain of MFN2 to promote
mitochondrial fusion (Huang et al., 2011).
DRP1 regulation
The complexity of Drp1 regulation has been recently reviewed
(Elgass et al., 2013; Otera et al., 2013), here we will briefly
summarize some critical steps. Drp1-dependent mitochondrial
fission is regulated by post-translational modifications like
ubiquitination, phosphorylation and SUMOylation to ensure
a rapid adaptation to cellular needs (Otera et al., 2013). For
example, Drp1 is targeted for proteasomal degradation by
Parkin-mediated ubiquitination (Wang et al., 2011) while the
ubiquitination mediated by MARCHV/Mitol is controversial
with different outcomes depending on cell context (Nakamura
et al., 2006; Karbowski et al., 2007). Sumoylation of Drp1
by the SUMO E3 ligase mitochondria-anchored protein ligase
(MAPL) stimulates mitochondrial fission (Braschi et al., 2009).
Phosphorylation of different residues of DRP1 cause opposing
effects. Duringmitosis, when organelles are inherited by daughter
cells, mitochondrial fission activity is promoted by Cdk1-cyclin
B-dependent Drp1 phosphorylation at Ser616 (in humans) in
the GTPase effector domain (GED) (Taguchi et al., 2007).
However, Drp1 activity is also induced by the posphorylation
of Ser637 in the GED by the calcium/calmodulin-dependent
protein kinase I alpha (CaMK1 alpha). As a result, this
phosphorylation increases mitochondrial translocation of Drp1
because it facilitates the interaction with Fis1 (Han et al., 2008).
However, phosphorylation of the same Ser637 by the protein
kinase A (PKA) has an opposite effect causing DRP1 retention
in the cytosol (Cribbs and Strack, 2007). This inhibition is
counteracted by the calcium dependent phosphatase, calcineurin
(Cribbs and Strack, 2007; Cereghetti et al., 2008). An interesting
model of how post-translational modulation of fission can
impinge on both, fusion and autophagy is what happens during
early stages of starvation. Under this condition, mitochondrial
fission is impaired due to the inhibition of Drp1. Two different
reports indicate that starvation in cells leads to increased
phosphorylation of Ser637 due to PKA activity as well as to
decreased phosphorylation of Ser616. As a consequence, Drp1
is retained in the cytosol and mitochondria are elongated
and spared from autophagic degradation. The resulting tubular
mitochondrial network displays an increased number and density
of cristae and presents more dimers of the ATP synthase (Gomes
et al., 2011; Rambold et al., 2011). In conclusion, the shaping
machinery adapts mitochondrial morphology to the bioenergetic
requirements of the cell determining the homeostasis and the
fate of the cell. Even though, our knowledge of the mechanisms
controlling mitochondria dynamics is growing, many aspects of
this process are still unclear.
Lysosomal-Dependent Degradation of
Mitochondria: Mitochondria-Derived
Vescicles (MDV) vs. Mitophagy
Depending from the type of injury, mitochondria can adopt
two different routes for delivering the damaged components to
lysosome for degradation. When mitochondria deterioration is
mild without global mitochondrial depolarization, local removal
of mitochondrial content can be done by the generation of
vesicles that bud-off from mitochondria and contain matrix
components (Soubannier et al., 2012a,b). These mitochondria-
derived vescicles (MDV) are 70–150 nm in size and do not
require the fission machinery for their biogenesis. MDVs
Frontiers in Physiology | www.frontiersin.org 5 January 2016 | Volume 6 | Article 422
Romanello and Sandri Mitochondria-Derived Signaling and Muscle Mass
carry oxidized proteins coming from different mitochondrial
compartments and are directed to lysosomes (Soubannier et al.,
2012b). Therefore, mitochondrial oxidative stress induces MDVs
via Pink-Parkin system (McLelland et al., 2014) independently
of the autophagy-related proteins Atg5, Rab9, or Beclin
(McLelland et al., 2014). Since Drp1 fission activity is not
required for MDV budding (Soubannier et al., 2012a,b), the
identification of the machinery necessary for MDV biogenesis
is still unknown. This system works in conjunction with
other mitochondria quality control pathways like mitochondrial
proteolysis and dynamics and precedes mitophagy. In fact, when
mitochondria are irreversibly damaged, they are excised from the
mitochondrial network by the fission machinery and sequestered
into autophagic vesicles for their degradation in the lysosome.
This selective mitochondrial degradation via autophagy is called
mitophagy. Apart from removal of dysfunctional mitochondria,
mitophagy is essential for mitochondria turnover in the basal
state and during the development of specialized cells such as
red blood cells (Sandoval et al., 2008). The loss of mitochondrial
membrane potential is a major trigger for mitophagy (Elmore
et al., 2001). The selectivity of mitophagy is controlled by
mitochondria dynamics and by the proteins PINK1, Parkin,
Bnip3L/Nix, and Bnip3.
Recessively inherited forms of Parkinson’s disease are
associated with loss-of-function mutations of the PTEN-induced
kinase 1 (PINK1) and the E3 ubiquitin ligase Parkin. Under
basal conditions Pink1 is imported into the IMM where it is
cleaved by PARL in a voltage dependent manner. The resulting
fragments will be further degraded by the cytosolic UPS (Jin
et al., 2010). Therefore, healthy mitochondria have undetectable
levels of PINK1. However, when 19m is lost, full length
PINK1 is not further imported and accumulates on OMM.
Here, PINK1 phosphorylates ubiquitin at Ser65 of ubiquitinated
OMM proteins and the ubiquitin-like domain of Parkin (Kane
et al., 2014; Kazlauskaite et al., 2014; Koyano et al., 2014).
Once phosphorylated, Parkin enhances the mitophagy signal by
generating more ubiquitin chains on OMM proteins that can be
further substrates for PINK1 (Lazarou et al., 2015). Subsequently,
the autophagic adaptors optineurin, NDP52 (Lazarou et al.,
2015) bind the phosphorylated ubiquitins tagging the OMM
proteins with LC3 to initiate mitophagy. The contribution
of the autophagy adaptor p62/SQSTM1 has been found to
be dispensable for mitophagy but important for perinuclear
clustering of depolarized mitochondria (Narendra et al., 2010;
Lazarou et al., 2015). However, these data were obtained
in vitro and thus the physiological relevance in vivo needs
to be validated. For instance, while p62 and NBR1 are well
expressed in adult muscles, optineurin and NDP52 proteins
are barely detectable (Nicot et al., 2014; Lazarou et al., 2015).
Bnip3 and Nix (also called Bnip3L) belong to the BH3-only
proteins and are implicated in both apoptosis and mitophagy.
These proteins translocate to mitochondria, form homodimers
and disrupt mitochondrial membrane potential (Sandoval et al.,
2008). They contain two evolutionary conserved LIR (LC3
Interacting Region) domains to bind LC3 and GABARAP. Nix
preferentially interacts with GABARAPwhereas Bnip3 binds LC3
(Novak et al., 2010; Hanna et al., 2012). These results indicate that
Bnip3 and Nix have an important role in mitochondrial turnover,
acting as autophagy receptors which tether the mitochondria to
the autophagosome. Moreover, the induction of autophagy by
the overexpression of Bnip3 in cardiomyocytes requires Drp1
translocation to mitochondria to mediate mitochondrial fission
(Lee et al., 2011).
UNRAVELING THE MECHANISMS LINKING
MITOCHONDRIAL FITNESS TO MUSCLE
HEALTH
Energy requirements during contraction in skeletal muscles
increase instantaneously up to 100-fold the consumption of ATP
(Blei et al., 1993; Gaitanos et al., 1993). Therefore, to support
this high demand of ATP, skeletal and cardiac muscles rely
on oxidative phosphorylation for energy production. Indeed
these tissues contain the greatest amount of mitochondria.
Several reports identified within the myofibers two distinct
mitochondrial populations that differ in their subcellular
localization, morphology as well as biochemical and functional
properties (Howald et al., 1985; Hoppeler et al., 1987; Romanello
and Sandri, 2013). Subsarcolemmal (SS) mitochondria are
located just underneath the sarcolemma and have a large,
lamellar shape. In contrast, the intermyofibrillar (IMF)
mitochondria are smaller, more compact, and located between
the contractile filaments. However, the existence of two separated
mitochondrial pools was challenged by recent findings on high-
resolution, three-dimensional electron microscopy (FIB-SEM).
Dahl and collaborators showed that SS and IMF are physically
connected in human muscles (Dahl et al., 2015). Moreover,
Ballaban’s lab identified 4 different mitochondrial morphologies:
the paravascular mitochondria (PVM), I-band mitochondria
(IBM), fiber parallel mitochondria (FPM), and cross fiber
connection mitochondria (CFCM) (Glancy et al., 2015). All these
mitochondria are highly interconnected forming a conductive
pathway that can rapidly distribute energy in the form of
electrical conduction throughout myofibers, enabling muscles to
respond immediately to changes in energy requirements.
Exercise and Peroxisome
Proliferator-Activated Receptor-γ
Coactivator-1 (PGC-1) Family Members
There is compelling evidence that regular exercise has many
beneficial effects for human health and life span (Neufer et al.,
2015). The effects of exercise are sensed by most organs including
cardiovascular, neuroendocrine, respiratory and musculoskeletal
systems. Importantly, some forms of exercise training counteract
skeletal muscle loss (Hourde et al., 2013; Cohen et al., 2015).
On the other hand, physical inactivity has been identified as the
fourth risk factor of morbidity/disability and mortality (Neufer
et al., 2015). Beneficial adaptations to endurance exercise training
(moderate intensity with prolonged duration) in skeletal muscle
include the activation of transcriptional dependent pathways
that impinge on mitochondrial biogenesis (Little et al., 2011),
mitochondrial quality and mitophagy (Grumati et al., 2011; He
et al., 2012a; Lo Verso et al., 2014).
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PGC-1α and PGC-1β
Mitochondrial biogenesis requires a coordinated action on
nuclear and mitochondrial genomes that is regulated by the
coactivators PGC-1α and PGC-1β (peroxisome proliferator-
activated receptor-γ coactivator-1α and β) PGC-1 family
members are preferentially expressed in tissues enriched
in mitochondria like heart, adipose tissue and slow-twitch
skeletal muscle. Exercise, fasting and cold exposure highly
regulate their expression. Since PGC-1α and PGC-1β are
coactivators that lack DNA binding domains, they elicit their
function by modulating the activity of several transcription
factors including PPARs, nuclear respiratory factors (NRFs),
myocyte enhancing factors (MEFs), estrogen-related receptor
(ERR), forkhead box (FoxOs), and yin-yang (YY1) (Lin et al.,
2005; Olesen et al., 2010; Zechner et al., 2010). Exercise
greatly stimulates PGC-1α via a transcription-dependent
upregulation and by several post-translational modifications
like phosphorylation and deacetylation (Wright et al., 2007;
Cantó et al., 2009; Egan et al., 2010). Moreover, acute endurance
exercise promotes the translocation of PGC-1α from the cytosol
to the nucleus (Wright et al., 2007) and mitochondria (Safdar
et al., 2011). This subcellular relocalization helps nuclear and
mitochondrial crosstalk to promote mitochondrial biogenesis
(Safdar et al., 2011). Indeed, both Tfam and nuclear gene
products are imported into mitochondria where they regulate
the expression of mitochondrial proteins required for ATP
synthesis. Interestingly, deletion of PGC-1α or PGC-1β in
mice showed mild phenotypes (Leone et al., 2005; Lelliott
et al., 2006; Vianna et al., 2006; Sonoda et al., 2007). Although,
exercise capacity was found reduced in PGC-1α knockout
mice (Leone et al., 2005; Handschin et al., 2007; Wende et al.,
2007), exercise-induced mitochondrial adaptations in PGC-1α
knockout mice were similar to wild-type animals (Leick et al.,
2008; Geng et al., 2010). These confilicting results can be
probably explained because these two coactivators are redundant
and partially compensate each other. In fact, when PGC-1β is
deleted on a generalized PGC-1α-deficient background (Zechner
et al., 2010) it was shown that these factors share a subset of
target genes and display overlapping functions. Accordingly,
exercise performance, in this model, is greatly decreased
compared to single PGC-1α or PGC-1β knockout animals
(Zechner et al., 2010). PGC-1α and PGC-1β are necessary for the
maintenance of mitochondrial function (Zechner et al., 2010).
Therefore, the deletion of both, PGC-1α and PGC-1β induce
severe mitochondrial dysfunction that leads to rapid depletion
of glycogen stores and to premature fatigue during exercise
(Zechner et al., 2010). Moreover, PGC-1α and PGC-1β control
mitochondrial dynamics by stimulating Mfn1 and Mfn2 gene
expression in a ERRα-dependent manner (Soriano et al., 2006;
Russell et al., 2013). Accordingly, Mfn1, Mfn2, and Drp1 are
severely downregulated in PGC-1α and PGC-1β muscle-specific
knockout mice (Zechner et al., 2010). Moreover, PGC-1α fine
tunes autophagy regulation during some forms of disuse atrophy
(Vainshtein et al., 2015). Therefore, PGC-1 coactivators not
only increase mitochondrial content but also mitochondrial
quality by modulating fusion/fission processes and mitophagy.
Surprisingly, PGC-1α and PGC-1β muscle-specific knockout
mice do not exhibit defects in muscle fiber type formation
in terms of myosin content (Zechner et al., 2010). This is in
contrast with a previous study that showed an increase of type
I fibers in transgenic mice that specifically express PGC-1α in
fast glycolytic muscles (Lin et al., 2002). PGC-1α mRNA levels
drop in different atrophying conditions like denervation (Sandri
et al., 2006), hind limb suspension (Cannavino et al., 2015)
aging (Chabi et al., 2008) or type 2 diabetic patients (Patti et al.,
2003). Importantly, maintaining PGC-1α levels high during
catabolic conditions, either by the use of transgenic mice or
by transfecting adult muscle fibers, spares muscle mass during
hind limb suspension, sarcopenia, cardiac cachexia, denervation,
fasting, or expression of constitutively active FoxO3 (Sandri
et al., 2006; Wenz et al., 2009; Geng et al., 2011; Cannavino et al.,
2015). Similar beneficial effects have been recently obtained by
overexpression of PGC-1β, an homolog of PGC-1α (Brault et al.,
2010). The positive action on muscle mass of these cofactors
is caused by the inhibition of the autophagic-lysosomal and
the ubiquitin proteasome degradation pathways. PGC-1α and
β reduce protein breakdown by inhibiting the transcriptional
activity of FoxO3 and NF-κB, but they do not affect protein
synthesis (Brault et al., 2010). Thus, these cofactors can prevent
the excessive activation of proteolytic systems by inhibiting
the action of the pro-atrophy transcription factors without
perturbing the translational machinery.
PGC-1α4
A new splicing variant transcript from PGC-1α gene, PGC-
1α4, was identified and shown to be involved in the regulation
of muscle mass (Ruas et al., 2012). PGC-1α4 expression is
induced with resistance exercise protocols (fewer repetitions
at high muscle loads aimed at increasing muscle mass) and
not with endurance exercise. Skeletal muscle-specific transgenic
overexpression of PGC-1α4 results into hypertrophic and
stronger mice (Ruas et al., 2012). PGC-1α4 controls muscle
mass by inducing IGF1 and repressing the myostatin pathway.
Importantly, PGC-1α4 overexpression counteract muscle loss
induced by hindlimb suspension and cancer-cachexia (Ruas et al.,
2012). However, the results obtained by Ruas and collegues are
in contrast with different reports analyzing exercise-mediated
adaptations in human muscles (Ydfors et al., 2013; Lundberg
et al., 2014; Silvennoinen et al., 2015). In humans, PGC-
1α4 is regulated transiently with exercise regardless of mode
(resistance or endurance) (Ydfors et al., 2013; Lundberg et al.,
2014; Silvennoinen et al., 2015). Moreover, chronic training
adaptations, such as increases in muscle mass and force do
not correlate with changes in the expression of PGC-1α4 after
resistance exercise or after the combination of aerobic and
resistance exercise (Lundberg et al., 2014).
Calcium and AMPK Signaling Pathways
The beneficial effects of exercise can be also mediated
by contraction-induced changes in calcium homeostasis,
ATP consumption and ROS production. The alteration in
calcium levels activates calcium-sensitive signaling such as
calcium/calmodulin-dependent protein kinases (CaMK) and
calcineurin/NFAT systems that are important for fiber type
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regulation and muscle plasticity (Wu et al., 2002; Blaauw et al.,
2013).
ER-mitochondria crosstalk is essential for excitation-calcium
coupling during muscle contraction. Indeed a great amount of
ATP produced by mitochondria is consumed by SERCA pumps.
Moreover, the positioning of intermyofibrillar mitochondria
nearby to SR makes them affected by the calcium wave
of contraction. In this context, the role of mitochondrial
calcium uptake in the maintenance of skeletal muscle mass
was recently investigated (Mammucari et al., 2015). In vivo
gain- and loss-of-function experiments in skeletal muscle showed
that modulation of mitochondrial calcium uniporter (MCU)
controls mitochondrial volume. Overexpression of MCU in
muscles leads to increased protein synthesis with a resulting
hypertrophic phenotype which impinge on IGF1/AKT and
PGC-1α4 pathways. Moreover, MCU overexpression protects
from denervation-induced atrophy. Supporting the importance
of MCU in skeletal muscle is the identification of mutations of
MICU1, an MCU regulator, in patients with proximal muscle
weakness, learning difficulties and extrapiramidal motor disorder
(Logan et al., 2014). In addition, different reports linked calcium
homeostasis with the control ofmusclemass (Blaauw et al., 2013).
Therefore, the investigation of calcium entry pathways in skeletal
muscle mitochondria open the possibility to better understand
the role of calcium in ER-mitochondria communication and its
impacts on muscle mass regulation.
On the other side ATP depletion modifies the AMP/ATP
ratio, activating the energy sensor AMP-activated protein kinase
(AMPK). The activation of this signal transducer is crucial for
the metabolic adaptations in response to energy stress. AMPK
inhibition of anabolic pathways together with stimulation of
catabolic pathways are aimed at conserving/restoring ATP (Ha
et al., 2015). In skeletal muscle AMPK activation is sufficient
to increase glucose uptake (by increasing GLUT4 translocation),
fatty acid oxidation and mitochondrial biogenesis. In fact,
AMPK-dependent phosphorylation of PGC-1α is required for
the induction of PGC-1α promoter and for the transcription of
many AMPK target genes (Jäger et al., 2007). Summarizing, both
calcium-dependent pathways and AMPK modulate the activity
and the expression of PGC-1α (Wu et al., 2002; Jäger et al., 2007).
Therefore, many of the beneficial effects of exercise converge
on the activation of PGC-1 signaling which is central for the
mitochondrial and metabolic adaptation to exercise.
Autophagy and ROS Production
Different reports demonstrated that acute as well chronic exercise
stimulates autophagy in different tissues (Grumati et al., 2011; He
et al., 2012a,b; Lo Verso et al., 2014). Experiments conducted in
inducible Atg7-deficient mice unraveled the mechanisms behind
autophagy induction following exercise (Lo Verso et al., 2014).
Interestingly, autophagy impairment does not affect exercise
performance suggesting that autophagy is not required to sustain
muscle contraction during exercise training (Lira et al., 2013; Lo
Verso et al., 2014). However, autophagy is critical for muscle
homeostasis after eccentric contractions. In fact, autophagy
is necessary to remove dysfunctional mitochondria that have
been altered by exercise in order to prevent excessive ROS
production (Lo Verso et al., 2014). It is well known that
exercise training and muscle contraction cause an increase
in ROS production and a transient oxidative stress (Davies
et al., 1982; Powers and Jackson, 2008). Indeed, oxidative
stress has an important role in muscle signaling (Finkel,
1998; Rhee et al., 2000; Sena and Chandel, 2012), but can
also induce damage to contractile proteins and organelles
(Carnio et al., 2014). Although counterintuitive, antioxidant
treatment leads to exercise intolerance in wild-type animals
and do not ameliorate the physical performance of autophagy-
deficient mice (Lo Verso et al., 2014). Moreover, control animals
treated with antioxidants display mitochondrial dysfunction and
autophagy impairment. Different reports support a crucial role
of oxidative stress signaling during exercise in the maintenance
of mitochondrial fitness (Gomez-Cabrera et al., 2005, 2008) and
in the induction of molecular regulators of insulin sensitivity
and antioxidant defense (Ristow et al., 2009). All together these
results are consistent with the mitohormesis concept (Ristow
and Schmeisser, 2014). Mitohormesis, the non-linear response
to mitochondrial ROS formation, exhibits a dual dose-response
(Ristow and Schmeisser, 2014). Accordingly, high ROS levels
are detrimental due to the induction of oxidative stress with
cellular damage. On the contrary, low ROS levels are essential
for maintenance of cellular function as well as for improving
oxidative stress for the promotion of health and lifespan (Ristow
and Schmeisser, 2011; Owusu-Ansah et al., 2013). Therefore,
understanding how mitohormesis is regulated could promise a
potential application in the promotion of cellular homeostasis
and longevity.
IGF1/PI3K/AKT/mTOR Pathway
Although both endurance as well as resistance exercise can
promote significant health benefits, the molecular response
signature will be different according to the frequency, intensity,
duration and the type of exercise (resistance or endurance). The
objectives of resistance exercise are an increase in muscle mass,
strength and power. The resistance exercise-induced adaptive
hypertrophic response is mediated by the anabolic factor insulin
growth factor 1 (IGF1) via the IGF1/PI3K/AKT/mTOR pathway.
Indeed, increased IGF1 levels precedes muscle hypertrophy
achieved by functional overload (Adams and Haddad, 1996).
Moreover, IGF1 stimulates fatty acid uptake and insuling
sensitivity (Clemmons, 2012) explaining in part some of the
beneficial effects of exercise. ATP citrate lyase (ACL) is a cytosolic
enzyme that catalyzes the conversion of mitochondria-derived
citrate into oxaloacetate and Acetyl-CoA important for lipid
synthesis and acetylation. ACL activity is controlled by a post-
translational modification via the IGF1/PI3K/AKT pathway.
Overexpression of ACL in muscles improved mitochondrial
function via stabilization of respiratory chain supercomplexes
formation due to increases in cardiolipin synthesis (Das
et al., 2015). Thus, IGF1 treatment of myotubes significantly
increases mitochondrial respiration due to IGF1-dependent
ACL activation suggesting that the activation of the IGF1-
ACL pathway increases protein synthesis as well as stimulating
the formation of the ATP necessary for this anabolic process
(Das et al., 2015). The correlation of mitochondrial fitness
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to muscle homeostasis is confirmed by the fact that ACL
overexpression in human myotubes is sufficient to induce
hypertrophy while ACL activity is downregulated in sarcopenic
and in dexamethasone-induced atrophic muscles (Das et al.,
2015). All together, these different models offer a useful
platform to further investigate the molecular mechanisms
explaining how improvements in mitochondrial function can be
translated into an increase in protein synthesis and therefore in
hypertrophy.
HOW DOES MITOCHONDRIAL
DYSFUNCTION ACTIVATE MUSCLE
PROTEOLYTIC PATHWAYS?
Muscle atrophy is an active process, controlled by specific
signaling pathways and transcriptional programs (Lecker et al.,
2004; Sandri, 2013). Of note, the muscle wasting transcriptome
signature is characterized by the coordinated reduction of
genes encoding key enzymes for ATP production and glycolysis
(Lecker et al., 2004). Accordingly, alterations in mitochondrial
morphology and function are frequently associated with
atrophying muscles in aging (see Section “The Role of Disrupted
Mitochondria Quality Control Pathways in Aging Sarcopenia”)
as well as in several wasting conditions such as burn injury
(Porter et al., 2013), intensive care unit-acquired weakness
(Friedrich et al., 2015), insulin resistance (Crescenzo et al.,
2014), chronic obstructive pulmonary disease (COPD) (Mathur
et al., 2014), cancer cachexia (Antunes et al., 2014), and
in different neuromuscular disorders (Katsetos et al., 2013).
Over the last years, several in vivo genetic perturbation
models indicate a key role of mitochondrial morphology
and mitochondrial dysfunction signaling in the activation of
nuclear programs controlling muscle loss. The maintenance
of a functional mitochondrial network is indeed particularly
important for tissues that are highly structured and metabolically
active such as neurons, cardiac and skeletal muscles. These
tissues are constituted by post-mitotic cells that do not
divide and consequently, cannot dilute damaged/dysfunctional
mitochondria through cellular division. Therefore, post-mitotic
tissues depend on the activation of mitochondria quality control
pathways to preserve or restore mitochondrial function.
Mitochondrial damage is attenuated with different defensive
strategies including the activation of mitochondrial proteolytic
systems, mitochondrial dynamics and the lysosomal degradation
of mitochondrial cargo. For this reason, a failure in any
of these systems predisposes to tissue dysfunction and
degeneration (Figure 2). The importance of the actions
of mitochondrial proteases, which remove misfolded or
damaged mitochondrial proteins, in the control of muscle
mass was confirmed by data obtained with several knockout
animal models. Loss in the activities of the proteases PARL
FIGURE 2 | Mitochondria-derived signaling pathways controlling muscle mass. Mitochondrial network accumulates damage when the mitochondrial quality
control mechanisms are impaired. ROS produced by the defective organelles induces muscle atrophy through the activation of the JNK-FoxO signaling pathway and
of ER stress. Moreover, the release of dangerous factors such as AIF, cytochrome c and ROS can induce apoptosis and/or necroptosis. The activation of the energy
sensor AMPK by an increase in the AMP/ATP ratio inhibits mTOR and directly phosphorylates FoxO3 (Ser413 and Ser588) increasing its transcriptional activity,
affecting muscle mass. The dashed line indicates a mechanism that needs more studies.
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(Cipolat et al., 2006), Omi/HtrA2 (Jones et al., 2003; Martins
et al., 2004), and Hax1 (Chao et al., 2008) lead to a similar
phenotype, characterized by mitochondrial dysfunction,
increased apoptosis, neurodegeneration and atrophy. A fine
equilibrium of mitochondrial fusion/fission processes is needed
to preserve muscle mass and prevent muscle wasting. This
balance is regulated according to the physiological needs of
cells.
Fusion Machinery and Atrophy
Fused mitochondria are preferred when optimal mitochondrial
function is needed. Indeed intermixing of mitochondrial content
by mitochondrial fusion increases the bioenergetic capacity
of the cell and is essential for the excitacion-contraction
coupling in skeletal muscles (Eisner et al., 2014). Moreover,
under conditions of high energy demand, mitochondrial fusion
has a survival function, by protecting mitochondria against
mitophagy, optimizing ATP production and leading to a
sustained cell viability during nutrient deprivation (Gomes et al.,
2011; Rambold et al., 2011). The biological importance of
mitochondrial fusion in early development is revealed by the
embryonic lethality of mouse knockouts for Opa1, Mfn1, and
Mfn2 (Chen et al., 2003; Davies et al., 2007). However, few
conditional tissue-specific knockout mice have been generated
(Chen et al., 2011; Zhang et al., 2011) and some of them
show a lethal phenotype therefore, limiting the studies of the
role of these factors in mitochondrial function in adulthood.
Therefore, little is known about the contribution of fusion
machinery to mitochondrial function and tissue homeostasis
in most tissues in vivo, including skeletal muscle fibers. The
neurodegenerative disorders dominant optic atrophy (DOA)
(Amati-Bonneau et al., 2008) and Charcot-Marie-Tooth type
2A (CMT2A) (Zuchner et al., 2004), are associated with loss
of function mutations of Opa1 and Mfn2 genes, respectively.
Noteworthy, patients affected with both DOA and CMT2A
develop myopathies (Yu-Wai-Man et al., 2010; Feely et al.,
2011). Likewise, neuromuscular defects related to precocious
age-dependent axonal and myelin degeneration are present in
mouse models resembling the Opa1 mutations most frequently
associated with DOA patients (Alavi et al., 2009; Sarzi et al.,
2012). Skeletal muscle from these models have alterations at
the ultrastructural level with increased smaller mitochondria.
In addition, mitochondria display disorganized cristae and
accumulate lipid droplets (Sarzi et al., 2012).
Opa1 and Muscle Mass
Further support in the role of Opa1 in the homeostatic control
of muscle mass comes from the observations obtained with a
genetic model of controlled Opa1overexpression (Civiletto et al.,
2015; Varanita et al., 2015). Opa1 transgenic mice are protected
from acute muscle loss induced by denervation (Varanita et al.,
2015) as well as from chronic muscle loss in a model of myopathy
caused by muscle-specific deletion of the mitochondrial subunit
COX15 (Civiletto et al., 2015). The analysis of the expression
levels of the major atrogenes belonging to the ubiquitin-
proteasome and of the autophagy-lysosome systems revealed a
reduction of MuRF1 and LC3 expression levels in denervated
Opa1 transgenic muscles. Furthermore, increased levels of Opa1
during denervation were sufficient to blunt denervation-induced
mitochondrial dysfunction (Varanita et al., 2015).
Mfn2 and Muscle Loss
In line with the relevance of mitochondrial fusion proteins in
the normal physiology of skeletal muscles, Mfn2 downregulation
induces changes in ER-mitochondria communication that
alters mitochondrial calcium buffering (Sebastian et al., 2012;
Ainbinder et al., 2015). Moreover, Mfn2 protein levels are
reduced in several catabolic conditions (Bach et al., 2005;
Hernandez-Alvarez et al., 2010; Lokireddy et al., 2012). Mul1 is a
FoxO-dependent ubiquitin-ligase involved in the ubiquitination
and further degradation of Mfn2 during muscle atrophy.
Accordingly, the maintenance of high Mfn2 proteins levels in
starvedmuscles achieved by the downregulation ofMul1 partially
protected from starvation-induced muscle loss (Lokireddy et al.,
2012). On the contrary, the ablation of Mfn1 and Mfn2 in
muscle-specific knockout mice induces a profound muscle
atrophy. These models display mitochondrial dysfunction and
compensatory mitochondrial proliferation, reduction of mtDNA
as well as accumulation of point mutations and deletions of
the mitochondrial genome (Chen et al., 2010). Mechanistically,
Mfn2 deficiency in muscles induces a remodeling of the
mitochondrial network leading to mitochondrial dysfunction
and ROS production (Sebastian et al., 2012). Oxidative stress
signaling is sufficient to activate an UPR that blunts insulin
signaling via JNK and leads to insulin resistance (Sebastian et al.,
2012). Mitochondrial fission is an essential component of the
mitochondrial quality control mechanism. When mitochondria
divide, two organelles are generated, one with high membrane
potential that might undergo fusion and another fragment with
low mitochondrial potential and reduced levels of OPA1 that will
not rejoin the mitochondrial network and will be likely removed
by autophagy (Twig et al., 2008).
Fission Machinery and Atrophy
Impairment of fission leads to the disruption of the selective
mitochondrial autophagic degradation followed by accumulation
of dysfunctional organelles (Twig et al., 2008; Dagda et al.,
2009; Kageyama et al., 2014; Ikeda et al., 2015; Song et al.,
2015). In fact, mutations in mitochondrial fission components
can be lethal. An infant girl born with a dominant-negative
mutation of Drp1 presented alterations in brain development
and in metabolism that cause neonatal lethality (Waterham et al.,
2007). Moreover, genetic perturbations leading to the ablation
of Drp1 in heart or brain are lethal (Ishihara et al., 2009;
Wakabayashi et al., 2009; Kageyama et al., 2014; Ikeda et al., 2015;
Song et al., 2015). Three different reports investigate Drp1 role
in heart physiology. Disrupted mitochondrial fission, obtained
with cardiac-specific ablation of Drp1, induces accumulation of
defective mitochondria due to impaired autophagy/mitophagy,
that over-time promotes cardiomyocyte death (Kageyama et al.,
2014; Ikeda et al., 2015; Song et al., 2015). In addition,
abnormalities in mitochondrial fission has also been implicated
in neurodegenerative disorders such as Alzheimer’s, Huntington,
and Parkinson (Chaturvedi and Flint Beal, 2013). In skeletal
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muscle, atrophying conditions such as fasting, denervation or
the overexpression of a constitutively active form of FoxO3
are characterized by alterations of the mitochondrial network
(Romanello et al., 2010). Furthermore, the disruption of the
mitochondrial network is a crucial amplificatory loop for the
muscle atrophy program. The acute overexpression in muscles of
the fission machinery per se promotes changes of mitochondrial
morphology which are followed by mitochondrial dysfunction,
energy stress and AMPK activation. As a consequence, AMPK
modulates FoxO3 transcriptional activity in order to induce
muscle atrophy via the activation of ubiquitin-proteasome and
autophagy pathways (Romanello et al., 2010). Accordingly,
inhibition of fission machineries or downregulation of AMPK is
sufficient to protect against muscle loss in atrophying conditions
(Romanello et al., 2010). These findings pave the way to further
investigate the causal link between changes in mitochondria
morphology and alterations in muscle homeostasis. A recent
report investigates the consequences of mitochondrial network
remodeling on muscle growth. The constitutive muscle-specific
overexpression of Drp1 (Touvier et al., 2015) leads to muscle
mass loss and decreased exercise performance (Touvier et al.,
2015). In this mouse model, stress-induced mitochondria-
dependent signals activate both, the UPRmt and the eIF2α-ATF4-
Fgf21 axis causing a reduction in protein synthesis and a blockade
of growth hormones actions that preventmuscle growth (Touvier
et al., 2015).
Autophagy and Atrophy
Mitophagy is a housekeeping mechanism important to keep
under control the turnover of mitochondria in both, the basal
state as well as under stress conditions. A finely tuned autophagic
system is required for muscle maintenance. Notably, genetic
manipulations to activate or inhibit autophagy results into
muscle atrophy (Mammucari et al., 2007; Masiero et al., 2009;
Romanello et al., 2010). Therefore, autophagy needs to be
properly regulated, otherwise it can become detrimental instead
of being protective. Several lines of evidence demonstrate that
constitutive basal autophagy, which preserves mitochondrial
function, is crucial for skeletal muscle homeostasis. Indeed,
dysregulation of autophagic flux is detrimental for myofiber
health and is a common feature of a group of muscle
disorders with alterations of lysosomal proteins such as Danon
or Pompe Disease as well as in the Vici Syndrome (Sandri
et al., 2013). Moreover, defective autophagy plays a role in
congenital muscular dystrophies caused by defects in collagen VI
production (Grumati et al., 2010), laminin A/C (Ramos et al.,
2012), or dystrophin (De Palma et al., 2012). These dystrophic
models have in common a hyperactivation of Akt/mTOR
signaling pathway that inhibits autophagy. Dystrophic muscles
present accumulation of structurally altered mitochondria
together with myofiber degeneration. Noteworthy, reactivation
of autophagy flux by dietary or pharmacological tools, like
rapamycin, cyclosporine A, or AICAR rescues the dystrophic
phenotype by clearing the abnormal mitochondria (Grumati
et al., 2010; De Palma et al., 2012; Pauly et al., 2012; Ramos
et al., 2012). In agreement, suppression of autophagy by
muscle-specific ablation of Atg5 and Atg7, the E3 ubiquitin
ligases necessary for autophagosome formation, exacerbates
fasting- and denervation- induced atrophy (Masiero et al., 2009).
Moreover, impairment of autophagy induces accumulation of
abnormal mitochondria, induction of oxidative stress, apoptosis,
muscle atrophy, weakness and several features of myopathy
(Raben et al., 2008; Masiero et al., 2009). Likewise, reduction
of mitophagy caused by ablation of Pink and Parkin induces
mitochondrial dysfunction and increased sensitivity to oxidative
stress followed by muscle degeneration (Clark et al., 2006; Park
et al., 2006; Billia et al., 2011). On the contrary, autophagic flux
is increased in muscles in both exercise (Grumati et al., 2011; Lo
Verso et al., 2014) and catabolic conditions (Sandri, 2013). For
example, in skeletal muscle, mitochondrial dysfunction caused
by the transient overexpression of FoxO3, Mul1 (Lokireddy et al.,
2012), Bnip3, or Nix (Romanello et al., 2010) triggers autophagy
and induces muscle atrophy (Mammucari et al., 2007; Romanello
et al., 2010). Naf-1, the nutrient-deprivation autophagy- factor 1,
is a ER-Bcl2 interacting protein identified as a novel autophagy
regulator. Its downregulation is accompanied by the presence of
abnormal mitochondria and increased autophagy that leads to
muscle weakness and atrophy (Chang et al., 2012).
Mitophagy Impairment and ROS Production
Oxidative stress is increased when autophagy is dysregulated.
ROS has detrimental effects both within and outside
mitochondria. Indeed, autophagy deficient muscle show an
increase of myosin and actin oxidation that reduces their sliding
properties and causes muscle weakness. Anti-oxidant treatment
restores a normal force generation and sliding properties even if
it does not rescue muscle atrophy (Carnio et al., 2014). Mutations
of the Superoxide Dismutase (SOD1) gene is behind 20% of
cases of inherited amyotrophic lateral sclerosis (ALS). ALS
is a neurodegenerative disease characterized by motoneuron
degeneration and muscle atrophy. Aberrant ROS production
affects mitochondrial function producing a feedback loop
that in turn exacerbates mitochondrial damage. Transgenic
muscle-specific mice expressing the SOD1 G93A mutation, an
ALS-associated human SOD1 mutation display muscle atrophy
which is mainly through autophagy activation (Dobrowolny
et al., 2008).
Autophagy and Muscle Metabolism
Skeletal muscle plays a significant role in the metabolic
control of glucose, lipids, and energy. Importantly, these
processes are coordinated with changes in mitochondrial
content, shape, and/or function. Therefore, the question now
arises as to how modulation of the mitochondrial quality
pathways and specifically of mitophagy can affect muscle
metabolism. Despite conflicting results, two different studies
investigate the connection between autophagy/mitophagy and
metabolic regulation in muscles. The first one, uses transgenic
mice with knock-in mutations on Bcl2 phosphorylation sites that
cannot trigger autophagy by fasting or exercise. These mice show
decreased exercise endurance, impaired exercise-induced glucose
uptake and are more sensitive to high fat diet-induced glucose
intolerance (He et al., 2012a). Since the transgene is expressed
in all cell types, it cannot be ruled out whether the observed
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effects are resulting from the combination of the actions exerted
by different metabolically active tissues (liver, heart, muscle,
brain). In the second study, muscle-specific autophagy deficient
mice (Atg7 knockout) are protected from high-fat diet induced
obesity and insulin resistance. The protective effects depend
on dysfunctional mitochondrial signals sufficient to activate an
UPR via ATF4, which induces Fgf21 expression (Kim et al.,
2013). Therefore, it is not clear how autophagy can fine-tune
the metabolic pathways in response to different cellular cues.
An important future goal is to establish the metabolic impact of
mitochondrial quality control pathways in skeletal muscle.
Oxidative Stress and Atrophy
As already discussed, ROS act in a hormetic fashion (Ristow
and Schmeisser, 2014). The beneficial or detrimental action
will depend on the level and persistance of ROS flow, as
well as on the antioxidant capacity of target cells (Barbieri
and Sestili, 2012). While low levels of ROS are associated
with positive effects on muscle physiology, on the other
hand, excessive production of free radicals accelerates muscle
proteolysis (Powers et al., 2012; Reid et al., 2014). Accordingly,
the exposure of oxidants to myotubes results in muscle atrophy
(McClung et al., 2009; Gilliam et al., 2012). In addition, several
models of disuse atrophy like mechanical ventilation, limb
immobilization, hindlimb unloading or bed rest are associated
with increased ROS production (Pellegrino et al., 2011). Recent
evidence indicates mitochondrial ROS production as a required
signaling step to induce mitochondrial dysfunction and muscle
disuse atrophy (Min et al., 2011; Powers et al., 2011; Talbert
et al., 2013b). Mechanistically, oxidative stress can impinge on
proteolytic pathways in multiple ways; First, ROS can regulate
NF-kB and FoxO transcriptional factors (Dodd et al., 2010)
activating the autophagy-lysosome and the ubiquitin-proteasome
systems (Taillandier et al., 1996; Levine et al., 2008, 2011;
Andrianjafiniony et al., 2010; Hussain et al., 2010; Brocca et al.,
2012). Second, the muscle proteases calpain (Taillandier et al.,
1996; McClung et al., 2009; Andrianjafiniony et al., 2010; Nelson
et al., 2012; Talbert et al., 2013a) and caspase-3 (Levine et al.,
2008; Nelson et al., 2012; Talbert et al., 2013a) are activated
during disuse atrophy. Third, oxidized proteins are more prone
to proteolysis because: (a) their susceptibility to be degraded by
caspase-3 and calpain is enhanced, in part because of unfolding
of the proteins (Smuder et al., 2010), (b) they can be directly
degraded by the proteasome without being ubiquitinated (Grune
et al., 2003), and (c) ubiquitin conjugation activity is increased by
oxidative stress (Shang et al., 1997).
Summarizing, all these data strongly support the involvement
of mitochondrial morphology and/or function in the activation
of signaling pathways that control muscle mass.
THE ROLE OF DISRUPTED
MITOCHONDRIA QUALITY CONTROL
PATHWAYS IN AGING SARCOPENIA
Sarcopenia is defined as the progressive age-related decline
in muscle mass and force. It is considered a primary risk
for developing major human pathologies that can result into
disability and increased vulnerability to death. It has been
estimated that roughly, 1.1 and 1.9/kg of muscle mass are lost
per decade in women and men, respectively (Janssen et al., 2000).
Of note, muscle strength precedes muscle loss, declining three-
times faster than muscle loss (Goodpaster et al., 2006). Age-
associated muscle loss begins at a slow rate around 30 years
of age, then it accelerates and starts to be noticeable after 45
years of age (Janssen et al., 2000). Beyond the sixth decade
of life more severe alterations such as spinal motor neurons
alterations can be observed (Booth et al., 1994) while the most
affected age is over 80 years old (Cruz-Jentoft et al., 2010). The
average life expectancy of human beings is rapidly increasing.
According to the National Institute on Aging (NIH), in 2010
8% of the world’s population were people over 65 years old
and this number is expected to double by 2050. Although the
resulting clinical, economical and social relevance of sarcopenia,
the mechanisms that drive the age-related loss of muscle mass
and function are not completely understood. Sarcopenia is a
complexmultifactorial process. Recently, nine primary hallmarks
of aging were specified (Lopez-Otin et al., 2013). Among these,
mitochondrial dysfunction has been long suggested as one of the
mechanisms of aging sarcopenia (Trounce et al., 1989; Melov
et al., 2007; Gouspillou et al., 2010, 2014a,b; Picard et al., 2011;
Carnio et al., 2014).
Decreased Mitochondrial Biogenesis
It has been shown that muscle mitochondrial content declines
with age (Conley et al., 2000; Short et al., 2005; Chabi
et al., 2008), however, there is no clear consensus (Mathieu-
Costello et al., 2005; Callahan et al., 2014; Gouspillou et al.,
2014b). Mitochondrial biogenesis is important for determining
mitochondrial content and function. It depends on the
transcription, translation and import of new proteins into
pre-existing organelles. In agreement to the observed age-
associated mitochondrial content reduction and dysfunction,
PGC1-α mRNA and protein levels are reduced in aged muscles
(Short et al., 2005; Chabi et al., 2008; Safdar et al., 2010; Ghosh
et al., 2011; Joseph et al., 2012; Ibebunjo et al., 2013). On
the other hand, muscle-specific PGC1-α transgenic mice are
protected from the reduction in mitochondrial function and
content observed during aging (Wenz et al., 2009). Moreover,
overexpression of PGC1-α is sufficient to prevent age-related
muscle loss (Wenz et al., 2009). Bluntedmitochondrial biogenesis
in aging is supported also by the fact that nascent mitochondrial
precursors are more prone to be degraded by cytosolic factors
(Huang et al., 2010).
Age-Associated Mitochondrial Oxidative
Damage
Several mechanisms necessary for mitochondrial homeostasis
are dysregulated in sarcopenia. In fact, during aging, ROS
production increases over a certain threshold, overcoming
cellular antioxidant defense. Therefore, the initial homeostatic
response of ROS signaling is subverted and accelerates the
age-associated damage (Lopez-Otin et al., 2013). The resulting
oxidative stress, induces post-translational modifications which
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compromise protein function (Baraibar et al., 2013). The
target proteins modified by oxidative stress (the oxy-proteome
components) in aged muscles have been identified recently, by
the resolution of carbonylated proteins (an indicator of oxidized
damaged proteins) by two-dimensional gel electrophoresis
(Lourenco Dos Santos et al., 2015). Many of them are
mitochondrial proteins which affect mitochondrial proteostasis
(Lourenco Dos Santos et al., 2015; Ross et al., 2015).
Mitochondrial Dynamics Changes
Despite certain discrepancy between reports, the balance between
fusion and fission is altered in sarcopenic muscles. Some studies
reported that muscle mitochondria in old rats are smaller than
young controls (Ljubicic et al., 2009; Iqbal et al., 2013). On the
other hand, giant mitochondria were observed in aged muscles
of houseflies (Rockstein and Bhatnagar, 1965), muscle cells of
humans (Beregi et al., 1988), mice (Beregi et al., 1988), and
rats (Navratil et al., 2008). Analysis of the longitudinal vs.
transversal mitochondrial orientation with transmission electron
microscopy reveals that muscle mitochondria from aged mice
are much more enlarged and branched than young muscles
(Leduc-Gaudet et al., 2015). Even though the authors did not
find any difference in the expression of the dynamic machineries
between young and old mice, they suggest that the alteration
of mitochondrial morphology in old muscles is the result of
a fusion/fission imbalance toward mitochondrial fusion (Bori
et al., 2012; Leduc-Gaudet et al., 2015). In contrast, other
groups find a downregulation only of Opa1 (Navratil et al.,
2008; Joseph et al., 2012) or an upregulation of the fission
machinery (Iqbal et al., 2013). Interestingly, a transcriptomic
and proteomic study found that reduced expression of all the
components of themitochondria dynamicmachineries correlates
with age-related muscle loss in rats (Ibebunjo et al., 2013). The
employment of new tools, like FIB-SEM, would be useful to
correlate mitochondrial dynamics alterations with mitochondrial
function in sarcopenic muscles.
The Role of Mitophagy in Sarcopenia
Several evidences indicate an alteration in mitochondrial
turnover during sarcopenia. Considering the decline of
mitochondrial biogenesis together with the progressive
accumulation of macromolecules and dysfunctional organelles
it seems to create a likely basis for impaired mitochondrial
function and removal during aging. In agreement, some
autophagic regulators like LC3 lipidation, Atg7, p62, beclin1,
Bnip3, Parkin, and LAMP2 decrease with age (Russ et al., 2012;
Joseph et al., 2013; Carnio et al., 2014; Gouspillou et al., 2014b).
Moreover, a genetic muscle-specific model of autophagy deletion
(Atg7 knockout mice) displays precocious aging characterized
by increased oxidative stress, mitochondrial dysfunction,
muscle loss and weakness and degeneration of neuromuscular
junctions. All together, these results put mitophagy central in
age-related mitochondrial dysfunction and critical to prevent
age-related denervation and weakness. In contrast, others
found increased levels of lipidated LC3 (Wenz et al., 2009),
Atg7, beclin1 (Fry et al., 2013), parkin, and p62 (O’Leary et al.,
2013). The divergence in these results highlight the necessity
of complementing the analysis of the expression of single
autophagic regulators with assays to evaluate the complete
autophagic process by flux measurements for the correct
interpretation of the results (Klionsky et al., 2012).
Interventions to Attenuate Mitochondrial
Dysfunction in Aging
Even though, aging sarcopenia is an unavoidable consequence
of getting old, it can be reduced with regular exercise and with
nutritional interventions. Notably, the benefits of both strategies
are mediated by activation of autophagy. Exercise training
increases mitochondrial content and turnover by activating both,
mitochondrial biogenesis (Little et al., 2011) and autophagy
(Vainshtein et al., 2014). As mitochondrial turnover and function
are both altered in sarcopenic muscles, exercise seems to be
a good countermeasure to improve mitochondrial function
(Jubrias et al., 2001; Short et al., 2003; Menshikova et al., 2006;
Melov et al., 2007) and therefore, to reduce the sarcopenic
process (Jubrias et al., 2001; Melov et al., 2007; Kern et al., 2014;
Zampieri et al., 2015). Interestingly, Melov et al. (2007) defined
the aging transcriptome signature. The sarcopenic muscle
profile was enriched with genes associated with mitochondrial
dysfunction compared with young muscles (Melov et al.,
2007).Genes important for energy production andmitochondrial
function decreased with age. Examples of these genes are the
genes encoding the ubiquinol-cytochrome C reductase hinge
protein (UQCRH), the β subunit of succinyl-CoA synthase
(SUCLA2), and the C subunit of succinate dehydrogenase (SDH).
Six months of resistance training were sufficient to revert
the transcriptome expression profile of the genes associated
with mitochondrial metabolism and electron transport to the
expression levels characteristic of young people. However, at
the functional/phenotypical levels resistance exercise partially
improved muscle strength (Melov et al., 2007). Importantly, the
benefits of exercise in reverting the sarcopenic phenotype do
not have the same effect on advanced age (over 80 years of
age) which have limited muscle plasticity (Slivka et al., 2008;
Raue et al., 2009), with the oldest ones being the most affected
by the consequences of aging muscle atrophy (Cruz-Jentoft
et al., 2010). Caloric restriction (CR) is a powerful nutritional
intervention that has been reported to increase lifespan, to
maintain metabolism at a more youthful-like state and to prevent
chronic diseases (Fontana and Partridge, 2015). The investigation
of the effects of lifelong CR in rats muscles demonstrated that
CR increases the expression of some autophagic proteins like
LC3, Atg7, and 9 and LAMP2 attenuating the age-dependent
decline in autophagy. Therefore, the chronic activation of
autophagy decreases oxidative damage as well as apopoptotic
DNA fragmentation and is sufficient to reduce age-related
myocyte degeneration maintaining skeletal muscle homeostasis
(Wohlgemuth et al., 2010). Chronic moderate CR adaptation
in muscles from humans (30% lower energy intake) and
rats is mediated by three major pathways: IGF1/insulin/FoxO,
mitochondrial biogenesis, and inflammation (Mercken et al.,
2013). CR-mediated responses lead to reduction of IGF1/AKT
pathway with the consequent increase of FoxO3 and 4 transcript
as well as an upregulation of FoxO-dependent antioxidant
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system and autophagy-related genes (Mercken et al., 2013).
Moreover, CR induces a transcriptional reprogramming profile
of molecular pathways that become more similar to the profile
of young individuals (Mercken et al., 2013). The involvement
of age-dependent mitochondrial decline in sarcopenia as well
as the physiological significance of this decline clearly needs
more studies. In years to come it will be exciting to see
if manipulations aimed at enhancing mitochondria quality
control pathways will be sufficient to promote a healthy aging
of muscles.
FINAL CONSIDERATIONS
In the last years our understanding of the different mechanisms
controlling mitochondrial morphology/function and the impact
of these pathways in the homeostatic control of muscle mass
has experienced an unprecedented advance. However, there
are still many challenges that should be addressed. First,
since the components of the mitochondria quality control
system are closely interconnected, the alteration in one system
can impinge on the activation/inhibition of the other repair
mechanism. Therefore, this interplay, which is of fundamental
importance for the integration of mitochondrial function within
the network, should be considered in future studies. Second,
mitochondria are social organelles that establish direct or indirect
(via mitochondria-derived vesicles) contacts with other cellular
components. Indeed, mitochondrial communication with the
endoplasmic reticulum, peroxisomes, and lysosomes/vacuoles
are hot topics of study at the moment. Then, it will be of
great interest to investigate the functional consequences of
these interactions in the physiology of muscle in the future.
Finally, mitochondria-derived metabolites can shuttle within
the cell and within the whole organism. Thus, exploring the
interrelation between mitochondria quality control pathways
and the metabolic regulation of muscle mass as well as the
muscle-interorgans crosstalk should give additional insights to
understand the way these relationships can be manipulated to
treat human diseases.
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